Valuation (88%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 7.44 | N/A |
| PEG Ratio (TTM) | 0.07 | N/A |
| P/S Ratio (TTM) | 10.73 | N/A |
| P/B Ratio (TTM) | 0.98 | N/A |
| P/FCF Ratio (TTM) | 11.30 | N/A |
| Price to 5YR AVG Earnings Ratio | 13.20 | N/A |
| Price to 5YR AVG FCF Ratio | 10.51 | N/A |
Profitability (60%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 9.23% | N/A |
| ROE (TTM) | 13.23% | N/A |
| Net Profit Margin (TTM) | 144.78% | N/A |
| ROIC 5YR AVG | 7.82% | N/A |
Growth (100%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 30.75% | 205.66% | 116.53% |
| Revenue | 156.54% | 217.43% | 126.88% |
| Net Income | 30.83% | 193.73% | 109.55% |
| Cash Flow | 160.76% | 86.38% | 339.55% |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | N/A | N/A |
| Quick Ratio (TTM) | N/A | N/A |
| D/E Ratio (TTM) | 0.33 | N/A |
| Interest Coverage (TTM) | 14.10 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 2.00 | N/A |
| LTL to 5YR AVG FCF | N/A | N/A |
| Shares Outstanding Growth 5YR AVG | -1.17% | N/A |